Products

Biaffin

Newsletter

kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant Biotinylated Human FGL1 (64-312) Protein, Avitag™,Fc Tag (high sensitivity), 25 µg  

Recombinant Biotinylated Human FGL1 (64-312) Protein, Avitag™,Fc Tag (high sensitivity), 25 µg

Recombinant Biotinylated Human FGL1 (64-312) Protein, expressed from human 293 cells (HEK293),  AA Asp 64 - Ile 312, Avitag, Fc-Tag (high sensitivity)

Synonym
recombinant, FGL1, Hepassocin, HP-041, HFREP-1, LFIRE-1, HFREP1, protein

More details

FG1-H82F6-25

Availability: within 7 days

420,00 €

Background
Fibrinogen-like protein 1(FGL1) is also known as HP-041, Hepassocin, HFREP-1, LFIRE-1. The protective effect of fibrinogen-like protein 1 (FGL1) in liver injury has previously been reported. However, studies have shown that FGL1 may be a predictor of GC patients and a target for GC therapy. Immunocytochemical studies revealed that fgl1 selectively binds to defective spermatozoa in the cauda epididymidis. Northern blot analysis and in situ hybridization demonstrated the high expression of fgl1 in the principal cells of the proximal cauda epididymidis. Immunofluorescence analysis using mouse fibrotic lung tissues suggested that fibrotic regions showed increased expressions of Gtse1 and Fgl1, Gtse1 and Fgl1 are suggested to be novel targets for radiation-induced lung fibrosis.

Source
Recombinant Biotinylated Human FGL1 (64-312), Avitag,Fc Tag (FG1-H82F6) is expressed from human 293 cells (HEK293). It contains AA Asp 64 - Ile 312 (Accession # Q08830-1). Predicted N-terminus: Gly

Molecular Characterization
This protein carries an Avi tag (Avitag™) at the N-terminus, followed by a human IgG1 Fc tag.
The protein has a calculated MW of 116.3 kDa. The protein migrates as 110-120 kDa under reducing (R) condition (SDS-PAGE).

Biotinylation
Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

Endotoxin
Less than 1.0 EU per μg by the LAL method.

Purity
>90% as determined by SDS-PAGE.

Formulation
Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 100 mM Glycine, 150 mM NaCl, pH7.5. Normally trehalose is added as protectant before lyophilization.

Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

Bioactivity
Please refer to product data sheet.